Company Filing History:
Years Active: 2015
Title: John Foerster: Innovator in Dermatological Research
Introduction
John Foerster is a notable inventor based in Dundee, GB. He has made significant contributions to the field of dermatological research, particularly in the treatment of inflammatory skin conditions such as psoriasis. His innovative work has led to the development of methods concerning PPAR delta and antagonists thereof.
Latest Patents
John Foerster holds 1 patent related to his research. His patent focuses on methods involving non-human animals that overexpress PPAR delta or express transgenic PPAR delta. These models are useful for screening test substances to assess their suitability for treating inflammatory skin conditions like psoriasis. One of the key substances mentioned in his patent is methyl 3-({[2-(methoxy)-4-phenyl]amino}sulfonyl)-2-thiophenecarboxylate, which can be administered topically for the prevention or treatment of psoriasis.
Career Highlights
Throughout his career, John Foerster has been associated with prestigious institutions such as the University Court of the University of Dundee and the University of Dundee. His work has been instrumental in advancing the understanding of inflammatory skin conditions and developing potential treatments.
Collaborations
John has collaborated with notable colleagues, including Colin Palmer and Nainamalai Sitherswaran. Their combined expertise has contributed to the success of his research endeavors.
Conclusion
John Foerster's innovative work in dermatological research has the potential to significantly impact the treatment of inflammatory skin conditions. His contributions to the field are noteworthy and demonstrate the importance of continued research and innovation in healthcare.